These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33337496)

  • 1. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
    Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
    JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program - Cherokee Nation, Oklahoma, 2015-2020.
    Essex W; Feder M; Mera J
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(22):597-600. PubMed ID: 37262000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, Oklahoma.
    Essex W; Mera J; Comiford A; Winters A; Feder MA
    J Community Health; 2023 Dec; 48(6):982-993. PubMed ID: 37531046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.
    Stvilia K; Spradling PR; Asatiani A; Gogia M; Kutateladze K; Butsashvili M; Zarkua J; Tsertsvadze T; Sharvadze L; Japaridze M; Kuchuloria T; Gvinjilia L; Tskhomelidze I; Gamkrelidze A; Khonelidze I; Sergeenko D; Shadaker S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(29):637-641. PubMed ID: 31344021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in Hepatitis C Screening and Treatment.
    Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
    Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease Burden and Outcomes Among American Indian and Alaska Native Medicare Beneficiaries.
    Eberly LA; Shultz K; Merino M; Brueckner MY; Benally E; Tennison A; Biggs S; Hardie L; Tian Y; Nathan AS; Khatana SAM; Shea JA; Lewis E; Bukhman G; Shin S; Groeneveld PW
    JAMA Netw Open; 2023 Sep; 6(9):e2334923. PubMed ID: 37738051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
    Olafsson S; Fridriksdottir RH; Love TJ; Tyrfingsson T; Runarsdottir V; Hansdottir I; Bergmann OM; Björnsson ES; Johannsson B; Sigurdardottir B; Löve A; Baldvinsdottir GE; Hernandez UB; Gudnason T; Heimisdottir M; Hellard M; Gottfredsson M
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):628-637. PubMed ID: 34171267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.
    Scott J; Fagalde M; Baer A; Glick S; Barash E; Armstrong H; Kowdley KV; Golden MR; Millman AJ; Nelson NP; Canary L; Messerschmidt M; Patel P; Ninburg M; Duchin J
    Hepatol Commun; 2021 Mar; 5(3):387-399. PubMed ID: 33681674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
    Kondili LA; Aghemo A; Andreoni M; Galli M; Rossi A; Babudieri S; Nava F; Leonardi C; Mennini FS; Gardini I; Russo FP
    Dig Liver Dis; 2022 Feb; 54(2):237-242. PubMed ID: 33926816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015.
    Nolen LD; O'Malley JC; Seeman SS; Bruden DJT; Apostolou A; McMahon BJ; Bruce MG
    Int J Circumpolar Health; 2019 Dec; 78(1):1608139. PubMed ID: 31025610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Progression of Diabetic Retinopathy in American Indian and Alaska Native Individuals Served by the Indian Health Service, 2015-2019.
    Fonda SJ; Bursell SE; Lewis DG; Clary D; Shahon D; Cavallerano J
    JAMA Ophthalmol; 2023 Apr; 141(4):366-375. PubMed ID: 36892822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan.
    Hu TH; Luh DL; Tsao YY; Lin TY; Chang CJ; Su WW; Yang CC; Yang CJ; Chen HP; Liao PY; Su SL; Chen LS; Hsiu-Hsi Chen T; Yeh YP;
    Am J Gastroenterol; 2024 May; 119(5):883-892. PubMed ID: 38084857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    Nasrullah M; Sergeenko D; Gvinjilia L; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Alkhazashvili M; Shadaker S; Ward JW; Morgan J; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):773-776. PubMed ID: 28749925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.